| Amir Mehdizadeh, MD | |
|
328 Shrewsbury St Ste 100, Worcester, MA 01604-5465 | |
| (508) 755-4861 | |
| Not Available |
| Full Name | Amir Mehdizadeh |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 8 Years |
| Location | 328 Shrewsbury St Ste 100, Worcester, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073976932 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207VX0000X | Obstetrics & Gynecology - Obstetrics | 284019 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians For Women's Health, Llc | 3274430665 | 278 |
News Archive
Glaucoma, a degenerative eye disease that causes damage to the optic nerve, is the second leading cause of blindness in the world, according to the World Health Organization. To observe Glaucoma Awareness Month, ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai and the Mount Sinai Health System are offering tips for prevention and early detection of the condition.
Allergan plc, a leading global pharmaceutical company, today announced that the Company has received approval from the U.S. Food and Drug Administration to market ACZONE (dapsone) Gel, 7.5%, a new prescription topical treatment for acne in patients 12 years of age and older.
Angiotech Pharmaceuticals, today announced that on February 1, 2011, Angiotech received a letter from the Toronto Stock Exchange stating that Angiotech's common shares will be delisted from the TSX effective at the close of market on March 3, 2011.
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced top-line results from a randomized, four-way crossover alcohol-interaction study in healthy male and female moderate drinkers with Egalet-002, an abuse-deterrent, extended-release, oral oxycodone-based product in development for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.
A multidisciplinary research group affiliated with the Department of Physical Education's Human Movement Laboratory at São Paulo State University in Bauru, Brazil, measured step length synergy while crossing obstacles in patients with Parkinson's disease and concluded that it was 53% lower than in healthy subjects of the same age and weight. Step length is one of the main variables affected by the disease.
› Verified 6 days ago
| Entity Name | Physicians For Women's Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801826680 PECOS PAC ID: 3274430665 Enrollment ID: O20200108001076 |
News Archive
Glaucoma, a degenerative eye disease that causes damage to the optic nerve, is the second leading cause of blindness in the world, according to the World Health Organization. To observe Glaucoma Awareness Month, ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai and the Mount Sinai Health System are offering tips for prevention and early detection of the condition.
Allergan plc, a leading global pharmaceutical company, today announced that the Company has received approval from the U.S. Food and Drug Administration to market ACZONE (dapsone) Gel, 7.5%, a new prescription topical treatment for acne in patients 12 years of age and older.
Angiotech Pharmaceuticals, today announced that on February 1, 2011, Angiotech received a letter from the Toronto Stock Exchange stating that Angiotech's common shares will be delisted from the TSX effective at the close of market on March 3, 2011.
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced top-line results from a randomized, four-way crossover alcohol-interaction study in healthy male and female moderate drinkers with Egalet-002, an abuse-deterrent, extended-release, oral oxycodone-based product in development for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.
A multidisciplinary research group affiliated with the Department of Physical Education's Human Movement Laboratory at São Paulo State University in Bauru, Brazil, measured step length synergy while crossing obstacles in patients with Parkinson's disease and concluded that it was 53% lower than in healthy subjects of the same age and weight. Step length is one of the main variables affected by the disease.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Amir Mehdizadeh, MD 119 Belmont St, Worcester, MA 01605-2903 Ph: (508) 334-1000 | Amir Mehdizadeh, MD 328 Shrewsbury St Ste 100, Worcester, MA 01604-5465 Ph: (508) 755-4861 |
News Archive
Glaucoma, a degenerative eye disease that causes damage to the optic nerve, is the second leading cause of blindness in the world, according to the World Health Organization. To observe Glaucoma Awareness Month, ophthalmologists at New York Eye and Ear Infirmary of Mount Sinai and the Mount Sinai Health System are offering tips for prevention and early detection of the condition.
Allergan plc, a leading global pharmaceutical company, today announced that the Company has received approval from the U.S. Food and Drug Administration to market ACZONE (dapsone) Gel, 7.5%, a new prescription topical treatment for acne in patients 12 years of age and older.
Angiotech Pharmaceuticals, today announced that on February 1, 2011, Angiotech received a letter from the Toronto Stock Exchange stating that Angiotech's common shares will be delisted from the TSX effective at the close of market on March 3, 2011.
Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today announced top-line results from a randomized, four-way crossover alcohol-interaction study in healthy male and female moderate drinkers with Egalet-002, an abuse-deterrent, extended-release, oral oxycodone-based product in development for the management of pain severe enough to require daily, around-the-clock opioid treatment and for which alternative treatments are inadequate.
A multidisciplinary research group affiliated with the Department of Physical Education's Human Movement Laboratory at São Paulo State University in Bauru, Brazil, measured step length synergy while crossing obstacles in patients with Parkinson's disease and concluded that it was 53% lower than in healthy subjects of the same age and weight. Step length is one of the main variables affected by the disease.
› Verified 6 days ago
Benjamin D. Hamar, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 119 Belmont St, Worcester, MA 01605 Phone: 508-334-0550 Fax: 508-334-8412 | |
Tara J. Chute, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 119 Belmont St, Worcester, MA 01605 Phone: 508-334-1000 | |
Isabel Karlins Sausjord, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 119 Belmont St Apt 401, Worcester, MA 01605 Phone: 508-334-6388 | |
Leah Wilson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 328 Shrewsbury St, Ste 100, Worcester, MA 01604 Phone: 508-755-4861 Fax: 508-752-1392 | |
Mr. Donald James Desio, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 123 Summer St, Suite 150 S, Worcester, MA 01608 Phone: 508-368-3110 Fax: 508-368-3113 | |
Anne E. Garrison, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 119 Belmont St, Worcester, MA 01605 Phone: 508-334-6255 | |
Debra M Papa, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 33 Kendall St, Department Of Obstetrics & Gynecology, Worcester, MA 01605 Phone: 508-334-6255 Fax: 508-334-6063 |